NCT00005900

Brief Summary

OBJECTIVES: I. Evaluate bronchoalveolar lavage fluid and serum obtained from pediatric patients with storage disorders prior to allogeneic hematopoietic stem cell transplantation (HSCT) for the presence of proinflammatory cytokines and for the production of nitric oxide by alveolar macrophages to identify possible risk factors for pulmonary complications. II. Investigate the underlying mechanism for the development of significant pulmonary complications in these patients during HSCT. III. Evaluate bronchoalveolar lavage fluid and serum obtained from these same patients at the time a pulmonary complication develops post-HSCT, or at 60 days post-HSCT if there has been no pulmonary complications.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 1999

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

June 2, 2000

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 5, 2000

Completed
Last Updated

June 24, 2005

Status Verified

October 1, 2003

First QC Date

June 2, 2000

Last Update Submit

June 23, 2005

Conditions

Keywords

Gaucher's diseaseI cell diseaseNiemann-Pick diseaseWolman diseaseadrenoleukodystrophydisease-related problem/conditionfucosidosisgenetic diseases and dysmorphic syndromesgloboid cell leukodystrophyinborn errors of metabolismmannosidosismetachromatic leukodystrophymucopolysaccharidosismucopolysaccharidosis Imucopolysaccharidosis VIoncologic disorderspulmonary complicationsrare diseasesphingolipidoses

Eligibility Criteria

Age0 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
* Diagnosis of an inborn error of metabolism eligible for allogeneic hematopoietic stem cell transplantation on protocol UMN-MT-1995-01

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

Fairview University Medical Center

Minneapolis, Minnesota, 55455, United States

Location

MeSH Terms

Conditions

MucolipidosesFucosidosisLeukodystrophy, Globoid CellAdrenoleukodystrophyMannosidase Deficiency DiseasesNiemann-Pick DiseasesMucopolysaccharidosis IMucopolysaccharidosis VILeukodystrophy, MetachromaticGaucher DiseaseWolman DiseaseGenetic Diseases, InbornMetabolism, Inborn ErrorsMucopolysaccharidosesRare DiseasesSphingolipidoses

Condition Hierarchy (Ancestors)

Bone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesLysosomal Storage Diseases, Nervous SystemBrain Diseases, Metabolic, InbornBrain Diseases, MetabolicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesCarbohydrate Metabolism, Inborn ErrorsLysosomal Storage DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesHereditary Central Nervous System Demyelinating DiseasesLeukoencephalopathiesDemyelinating DiseasesLipidosesLipid Metabolism, Inborn ErrorsLipid Metabolism DisordersX-Linked Intellectual DisabilityIntellectual DisabilityNeurobehavioral ManifestationsNeurologic ManifestationsGenetic Diseases, X-LinkedHeredodegenerative Disorders, Nervous SystemPeroxisomal DisordersAdrenal InsufficiencyAdrenal Gland DiseasesEndocrine System DiseasesHistiocytosis, Non-Langerhans-CellHistiocytosisLymphatic DiseasesHemic and Lymphatic DiseasesMucinosesConnective Tissue DiseasesSkin and Connective Tissue DiseasesSulfatidosisCholesterol Ester Storage DiseaseInfant, Newborn, DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • K. Scott Baker

    Fairview University Medical Center

    STUDY CHAIR

Study Design

Study Type
observational
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 2, 2000

First Posted

June 5, 2000

Study Start

August 1, 1999

Last Updated

June 24, 2005

Record last verified: 2003-10

Locations